Dana-Farber Cancer Institute: Study Finds Quality of Life Maintained With Active Monitoring for DCIS
December 13, 2024
December 13, 2024
BOSTON, Massachusetts, Dec. 13 (TNSres) -- The Dana-Farber Cancer Institute issued the following news release:
* * *
Women report having similar quality of life whether randomized to active monitoring or surgery for low-risk ductal carcinoma in-situ (DCIS) after two years of follow-up.
* * *
In the first large phase 3 randomized clinical trial in the U.S. to look at different management strategies for low-risk DCIS, Dana-Farber Cancer Institute . . .
* * *
Women report having similar quality of life whether randomized to active monitoring or surgery for low-risk ductal carcinoma in-situ (DCIS) after two years of follow-up.
* * *
In the first large phase 3 randomized clinical trial in the U.S. to look at different management strategies for low-risk DCIS, Dana-Farber Cancer Institute . . .